USFDA issues 11 observations for Sun Pharma's Dadra facility
Drug major Sun Pharmaceutical Industries has received 11 observations from the US health regulator after inspection of its Dadra facility.
Apr 22, 2017, 18:54 PM IST
USFDA completes inspection of Cadila's Changodar plant
Drug firm Cadila Healthcare today said the USFDA has completed inspection of its manufacturing plant at Changodar with "no observation".
Apr 07, 2017, 17:35 PM IST
Lupin launches generic insomnia drug in US
Drug major Lupin has launched a generic insomnia drug, Zolpidem Sublingual tablets, in the US market with 180-days of marketing exclusivity.
Apr 05, 2016, 13:56 PM IST
Dr Reddy's tanks 14.5 pc on USFDA warning
Shares of drug firm Dr Reddy's Laboratories today plunged 14.5 per cent after the company said it has received a warning letter from the US health regulator over inadequate quality control procedures at its three drug manufacturing units in India.
Nov 06, 2015, 13:02 PM IST
USFDA completes Nalagarh facility inspection: Wockhardt
Drug firm Wockhardt, which has been under the USFDA scanner, Thursday said that United States health regulator has completed inspection of its Nalagarh facility in Himachal Pradesh.
Jul 23, 2015, 20:34 PM IST
Sun Pharma unit recalls mutiple lots of capsules from US
Caraco Pharmaceutical Laboratories , a unit of Sun Pharma, has initiated a recall of multiple lots of Cephalexin capsules from the US market.
Aug 15, 2014, 11:15 AM IST
